These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5633424)

  • 61. [Myocardial infarct and the practitioner's emergency medical pouch: place of intensain].
    Mazuez J
    Therapeutique; 1970 Dec; 46(10):1049-52. PubMed ID: 5511934
    [No Abstract]   [Full Text] [Related]  

  • 62. [Fundamentals of successful coumarin long-term treatment].
    Loeliger EA; Hensen A
    Thromb Diath Haemorrh Suppl; 1964; 12():111-4. PubMed ID: 5882962
    [No Abstract]   [Full Text] [Related]  

  • 63. [Side effect of intensaine].
    Kurochkin NM; Belolipetskaia TA; Stepashkin AM
    Sov Med; 1973 Jul; 36(7):141. PubMed ID: 4776693
    [No Abstract]   [Full Text] [Related]  

  • 64. "Hobson's choice" clarification.
    Morgan JP
    Arch Intern Med; 1975 Aug; 135(8):1129. PubMed ID: 1156074
    [No Abstract]   [Full Text] [Related]  

  • 65. [The effect of esculamin on experimental influenza pneumonia in mice].
    Chernukh AM; Prokhorova AM; Rudakova IS; Tolmacheva NS
    Patol Fiziol Eksp Ter; 1967; 11(3):49-51. PubMed ID: 5254235
    [No Abstract]   [Full Text] [Related]  

  • 66. Changes in the state of the microvascular bed and in the extent of transcapillary exchange by preparations with P-vitamin activity.
    Rudakova IS; Chernukh AM
    Bibl Anat; 1969; 10():273-7. PubMed ID: 5407374
    [No Abstract]   [Full Text] [Related]  

  • 67. [Role of interferon in experimental viral diseases].
    German A; Quero AM
    Bull Acad Natl Med; 1983 Feb; 167(2):163-9. PubMed ID: 6196097
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effectof triftazin on experimental influenza infection].
    Chernukh AM; Tolmacheva NS
    Farmakol Toksikol; 1966; 29(2):206-9. PubMed ID: 6000348
    [No Abstract]   [Full Text] [Related]  

  • 69. [Controlled change in the physiologic state of cell membranes as one of the principles of influence on the course of a pathologic process].
    Chernukh AM; Rudakova IS
    Biull Eksp Biol Med; 1967 Nov; 63(11):60-4. PubMed ID: 5633424
    [No Abstract]   [Full Text] [Related]  

  • 70. [Present status of development of problem of microcirculation].
    Chernukh AM
    Vestn Akad Med Nauk SSSR; 1968; 23(2):8-16. PubMed ID: 4983219
    [No Abstract]   [Full Text] [Related]  

  • 71. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 72. Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart.
    Wayman NS; McDonald MC; Chatterjee PK; Thiemermann C
    Methods Mol Biol; 2003; 225():199-208. PubMed ID: 12769489
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of digitalis in patients with coronary artery disease.
    Gheorghiade M; Beller GA
    Cardiol Clin; 1984 Feb; 2(1):135-46. PubMed ID: 6399999
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL
    Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.